Walter Moos

Walter Moos

Director/Board Member at RIGEL PHARMACEUTICALS, INC.

Net worth: 563 211 $ as of 2026-05-30

71 year
Health Technology
Commercial Services
Finance

Profile

Walter H.
Moos
is the founder of Pandect Bioventures Management LLC, founded in 2018, serving as Managing Director.
Current jobs include Chairman at Keystone Symposia since 2000; Independent Director at Rigel Pharmaceuticals, Inc. since 1997; Director at Circle Pharma, Inc. since 2016; Member of the Board of Directors at Aprinoia Therapeutics, Inc. since 2018; Director at Valitor, Inc.; and Director at Organos, Inc. Former jobs include Chairman & Chief Executive Officer at MitoKor, Inc. from 1997 to 2004; Board Member and Acting/Interim CEO at Alnis Biosciences, Inc. from 2003 to 2005; Chairman at ShangPharma Innovation, Inc. in 2020; Director at MIGENIX, Inc. from 2004 to 2008; Director at Oncologic, Inc.; Director at Critical Path Institute; Director at Amunix, Inc.; Vice President at Chiron Corp.
from 1991 to 1997; VP-Neuroscience & Biological Chemistry at Pfizer Inc. from 1982 to 1991; Vice President-Neuroscience & Biological Chemistry at Warner-Lambert Co. from 1982 to 1991; Board Member at Onyx Pharmaceuticals, Inc. from 1993 to 1997; Board Member at Biotechnology Innovation Organization from 2001 to 2003; Executive Advisor at Aduro BioTech, Inc. from 2016 to 2020; Board Member at Anterion Therapeutics, Inc. from 2003 to 2005; President-Biosciences at SRI International from 2015 to 2016; Board Member and Chair at Mimotopes Pty Ltd.; Board Member at Axiom Biotechnologies, Inc. from 2001 to 2002; Advisor at Red Abbey Venture Partners LLC; Member of the Scientific Advisory Board at Global Blood Therapeutics, Inc. from 2016 to 2022; Board Member at Virginia University Research Partnership, Inc. from 2007 to 2015; Executive Advisor at Chinook Therapeutics, Inc. from 2016 to 2020; and Advisory Board Member at Cafe Scientifique Silicon Valley from 2007 to 2013.
Education includes an undergraduate degree from Harvard University conferred in 1976 and a doctorate from the University of California, Berkeley conferred in 1982.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-14 18,472 ( 0.1% ) 563 211 $ 2026-05-30

Walter Moos active positions

CompaniesPositionStart
RIGEL PHARMACEUTICALS, INC. Director/Board Member 1997-02-28
Chairman 1999-12-31
Founder 2018-09-30
Director/Board Member 2017-12-31
Director/Board Member -
Director/Board Member -
Director/Board Member -

Former positions of Walter Moos

CompaniesPositionEnd
Chief Executive Officer 2020-05-31
Consultant / Advisor 2022-12-22
░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░ ░░░░░░░ ░░░░░░░░░░
See the detail of Walter Moos's experience

Training of Walter Moos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

79

1st degree connections

31

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies31

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Electronic Technology

Commercial Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

Finance

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Virginia University Research Partnership, Inc.

Finance

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Cafe Scientifique Silicon Valley